Trial Details

COMPLETED
Basic Information
Clinical ID c1441
Identifier NCT03643211
Trial Title Xeljanz Special Investigation for Long-term Use in UC Patients
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Ulcerative Colitis
Interventions -
Participant Information
Sponsor Pfizer
City Tokyo
Country/Region Japan
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase -
Time Information
Start Date 2018-06-08
Primary Completion Date 2022-11-10
Completion Date 2022-11-10